(Q41493977)

1 October 2017

Single- and multiple-dose kinetics of oral lorazepam in humans: the predictability of accumulation (English)

1 reference

1 October 2017

1 reference

5

J S Harmatz

1 reference

1 October 2017

1

D J Greenblatt

1 reference

1 October 2017

6

R I Shader

1 reference

1 October 2017

2

M D Allen

1 reference

1 October 2017

D S MacLaughlin

3

1 reference

PubMed ID

20218012

1 October 2017

D H Huffman

series ordinal

4

1 reference

1 October 2017

1 April 1979

1 reference

Journal of Pharmacokinetics and Pharmacodynamics

1 October 2017

1 reference

1 October 2017

7

1 reference

1 October 2017

2

1 reference

1 October 2017

159-179

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01059736

1 October 2017

0 references

cites work

Clinical pharmacokinetics of lorazepam. I. Absorption and disposition of oral 14C-lorazepam

1 reference

https://api.crossref.org/works/10.1007%2FBF01059736

Clinical pharmacokinetics of lorazepam; II. Intramuscular injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059736

Clinical Pharmacokinetics of Lorazepam. III. Intravenous Injection. Preliminary Results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059736

Pharmacokinetics and Bioavailability of Intravenous, Intramuscular, and Oral Lorazepam in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059736

Statistical estimations in pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059736

Drug therapy. Clinical Pharmacokinetics (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059736

Clorazepate kinetics in treated epileptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059736

Clinical Pharmacokinetics of Lorazepam. IV. Long-Term Oral Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059736

Factors influencing antipyrine elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059736

Changes in D-glucaric acid excretion in relationship to alterations in the rate of antipyrine metabolism in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059736

Effects of Chronic Prazepam Administration on Drug Metabolism in Man and Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01059736

Impairment of antipyrine clearance in humans by propranolol

21 January 2018

1 reference

12 December 2020

Pharmacokinetics of chlordiazepoxide and metabolites following single and multiple oral doses

1 reference

12 December 2020

Analysis of lorazepam and its glucuronide metabolite by electron-capture gas--liquid chromatography. Use in pharmacokinetic studies of lorazepam

1 reference

12 December 2020

The estimation of antipyrine in biological materials

1 reference

12 December 2020

Relationship between plasma antipyrine half-lives and hepatic microsomal drug metabolism in dogs

1 reference

12 December 2020

1 reference

12 December 2020

Correlation of the plasma elimination of antipyrine and the appearance of 4-hydroxy antipyrine in the urine of man

1 reference

12 December 2020

Assessment of Pharmacokinetic Constants from Postinfusion Blood Curves Obtained after I.V. Infusion

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01059736

1 reference

1 October 2017

1 reference

PubMed ID

20218012